Follow-up and surveillance of the lung cancer patient following curative intent therapy: ACCP evidence-based clinical practice guideline (2nd edition)

Chest

Volumn 132, Issue 3 SUPPL., 2007, Pages 355S-367S

  Rubins, Jeffrey ^a,d   Unger, Michael ^b   Colice, Gene L ^c  

^a UNIVERSITY OF MINNESOTA   (United States)

^b FOX CHASE CANCER CENTER   (United States)

^c WASHINGTON HOSPITAL CENTER   (United States)

^d Pulmonary 111N ^*  (United States)

Author keywords

Lung cancer; Metachronous tumors; Recurrence; Surveillance

Indexed keywords

BLOOD CELL COUNT; CANCER EPIDEMIOLOGY; CANCER RECURRENCE; COMPUTER ASSISTED TOMOGRAPHY; EVIDENCE BASED MEDICINE; HUMAN; LUNG CANCER; PATIENT COUNSELING; PHYSICAL EXAMINATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SMOKING CESSATION; THORAX RADIOGRAPHY; ARTICLE; LUNG TUMOR; SECOND CANCER; TUMOR RECURRENCE;

EVIDENCE-BASED MEDICINE; HUMANS; LUNG NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, SECOND PRIMARY; SMOKING CESSATION;

EID: 34848838006     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.07-1390     Document Type: Article

References (108)

1. Cancer facts and figures. Atlanta, GA: American Cancer Society, 2005
2. Mountain CF. Revisions in the international system for staging lung cancer. Chest 1997; 111:1710-1717
3. Virgo KS, Johnson FE, Naunheim KS. Follow-up of patients with thoracic malignancies. Surg Oncol Clin North Am 1999; 8:355-369
4. Colice GL, Rubins J, Unger M. Follow-up and surveillance of the lung cancer patient following curative-intent therapy. Chest 2003; 123:272S-281S
5. BTS recommendations to respiratory physicians for organising the care of patients with lung cancer: the Lung Cancer Working Party of the British Thoracic Society Standards of Care Committee. Thorax 1998; 53(suppl):S1-S8
6. Handsy JR, Child AI, Grunkmeier GL. Hospital readmissions after pulmonary resection: prevalence: patterns and predisposing characteristics. Ann Thorac Surg 2001; 72:1855-1860
7. Nezu K, Kushibe K, Tojo T. Recovery and limitation of exercise capacity after lung resection for lung cancer. Chest 1998; 113:1511-1516
8. Katz J, Jackson M, Kavanagh BP, et al. Acute pain after thoracic surgery predicts long-term post-thoracotomy pain. Clin J Pain 1996; 12:55-60
9. Landreneau RJ, Mack MJ, Hazelrigg SR. Prevalence of chronic pain after pulmonary resection by thoracotomy or video-assisted thoracic surgery. J Thorac Cardiovasc Surg 1994; 107:1079-1086
10. Dajczman E, Gordon A, Kreisman H. Long-term postthoracotomy pain. Chest 1991; 99:270-274
11. Dales RE, Belanger R, Shamji FM. Quality-of-life following thoracotomy for lung cancer. J Clin Epidemiol 1994; 47:1443-1449
12. Li WWL, Lee TW, Yim APC. Quality of life after lung cancer resection. Thorac Surg Clin 2004; 14:353-365
13. Garces YI, Yang P, Parkinson J, et al. The relationship between cigarette smoking and quality of life after lung cancer diagnosis. Chest 2004; 126:1733-1741
14. Barker W, Langston HT, Naffah P. Postresectional spaces. Ann Thorac Surg 1966; 2:299-310
15. Silver AW, Espinas EE, Byron FX. The fate of the postresection space. Ann Thorac Surg 1966; 2:311-326
16. Suarez J, Clagett OT, Brown AL. The postpneumonectomy space: factors influencing obliteration. J Thorac Cardiovasc Surg 1969; 57:539-542
17. Grillo HC, Shepard J, Mathisen DJ, et al. Postpneumonectomy syndrome: diagnosis, management, and results. Ann Thorac Surg 1992; 54:638-651
18. Cox JD, Azarnia N, Byhardt RW. A randomized phase I/II trial of hyperfractionated radiation therapy with total doses of 60.0 Gy to 79.2 Gy. J Clin Oncol 1990; 8:1543-1555
19. Abratt RP, Morgan GW. Lung toxicity following chest irradiation in patients with lung cancer. Lung Cancer 2002; 35:103-109
20. Inoue A, Kunitoh H, Seldne I. Radiation pneumonitis in lung cancer patients. Int J Radiat Oncol Biol Phys 2001; 49:649-655
21. Hara R, Rami J, Komiyama T. Serum levels of KL-6 for predicting the occurrence of radiation pneumonitis after stereotactic radiotherapy for lung tumors. Chest 2004; 125:340-344
22. Miller KL, Zhou SM, Barrier RC Jr, et al. Long-term changes in pulmonary function tests after definitive radiotherapy for lung cancer. Int J Radiat Oncol Biol Phys 2003; 56:611-615
23. Choi NC, Kanarek DJ. Toxicity of thoracic radiotherapy on pulmonary function in lung cancer. Lung Cancer 1994; 10:S219-S230
24. Leo F, Solli P, Spaggiari L. Respiratory function changes after chemotherapy. Ann Thorac Surg 2004; 77:260-265
25. Martini N, Melamed MR. Multiple primary lung cancers. J Thorac Cardiovasc Surg 1975; 70:606-611
26. American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003. J Clin Oncol 2004; 22:330-353
27. Follow-up of non-small cell lung cancer: American College of Radiology appropriateness criteria, 2005. Available at: www.acr.org. Accessed August 21, 2007
28. National Comprehensive Cancer Network. Practice guidelines for non-small cell lung cancer. Rockledge, PA: National Comprehensive Cancer Network, 2000
29. Association of Community Cancer Centers. Oncology patient management guidelines, version 3.0. Rockville, MD: Association of Community Cancer Centers, 2000
30. Felip E, Pavlidis N, Stahel RA, et al. ESMO minimum clinical recommendations for diagnosis, treatment and follow-up of non-small-cell lung cancer (NSCLC). Ann Oncol 2005; 16(suppl):i28-i29
31. Felip E, Pavlidis N, Stahel RA, et al. ESMO minimum clinical recommendations for diagnosis, treatment and follow-up of small-cell lung cancer (SCLC). Ann Oncol 2005; 16(suppl):i30-i31
32. Depierre A, Lagrange JL, Theobald S. Summary report of the standards, options and recommendations for the management of patients with non-small-cell lung carcinoma (2000). Br J Cancer 2003; 89:S35-S49
33. Immerman SC, Vanecko RM, Fry WA. Site of recurrence in patients with stages I and II carcinoma of the lung resected for cure. Ann Thorac Surg 1981; 32:23-26
34. Pairolero PC, Williams DE, Bergstralh EJ. Postsurgical stage I bronchogenic carcinoma. Ann Thorac Surg 1984; 38:331-336
35. Iascone C, DeMeester TR, Albertucci M. Local recurrence of resectable non-oat cell carcinoma of the lung. Cancer 1986; 57:471-476
36. The Ludwig Lung Cancer Study Group. Patterns of failure in patients with resected stage I and II non-small-cell carcinoma of the lung. Ann Surg 1986; 205:67-71
37. Martini N, Bains MS, Burt ME. Incidence of local recurrence and second primary tumors in resected stage I lung cancer. J Thorac Cardiovasc Surg 1995; 109:120-129
38. Harpole DH, Herndon JE, Wolfe WG. A prognostic model of recurrence and death in stage I non-small cell lung cancer utilizing presentation, histopathology, and oncoprotein expression. J Cancer Res 1995; 55:50-56
39. Thomas P, Rubinstein L, and the Lung Cancer Study Group. Cancer recurrence after resection. Ann Thorac Surg 1990; 49:242-247
40. Thomas P, Rubinstein L, and the Lung Cancer Study Group. Malignant disease appearing late after operation for T1 N0 non-small-cell lung cancer. J Thorac Cardiovasc Surg 1993; 106:1053-1058
41. Baldini EH, DeCamp MM, Katz MS. Patterns of recurrence and outcome for patients with clinical stage II non-small-cell lung cancer. Am J Clin Oncol 1999; 22:8-14
42. Poon RB. Lightening can strike twice. Chest 2000; 118:1526-1529
43. Johnson BE. Second lung cancers in patients after treatment for an initial lung cancer. J Natl Cancer Inst 1998; 90:1335-1345
44. Pastorino U, Infante M, Miaoli M, et al. Adjuvant treatment of stage I lung cancer with high-dose vitamin A. J Clin Oncol 1993; 11:1216-1222
45. Rice D, Kim H, Sabichi A. The risk of second primary tumors after resection of stage I nonsmall lung cancer. Ann Thorac Surg 2003; 76:1001-1008
46. Levi F, Randimbison L, Te VC, et al. Second primary cancers in patients with lung carcinoma. Cancer 1999; 86:186-190
47. Rosengart TK, Martini N, Ghosn P, et al. Multiple primary lung carcinomas. Ann Thorac Surg 1991; 52:773-779
48. Duchateau CSJ. Second primary tumors involving non-small cell lung cancer: prevalence and its influence on survival. Chest 2005; 127:1152-1158
49. Saito Y, Sato M, Sagawa M, et al. Multicentricity in resected occult bronchogenic squamous cell carcinoma. Ann Thorac Surg 1994; 57:1200-1205
50. Bechtel JJ, Petty TL, Saccomanno G. Five year survival and later outcome of patients with x-ray occult lung cancer detected by sputum cytology. Lung Cancer 2000; 30:1-7
51. Van Schil PEY, Riviere AB, Knaapen PJ. Second primary lung cancer after bronchial sleeve resection. J Thorac Cardiovasc Surg 1992; 104:1451-1455
52. Johnson BE, Ihde DC, Matthews MJ. Non-small-cell lung cancer. Am J Med 1986; 80:1103-1110
53. Sagman U, Lishner M, Maki E. Second primary malignancies following diagnosis of small-cell lung cancer. J Clin Oncol 1992; 10:1525-1533
54. Smythe WR, Estrera AL, Swisher SG. Surgical resection of non-small cell carcinoma after treatment for small cell carcinoma. Ann Thorac Surg 2001; 71:962-966
55. Watanabe Y, Shimuzu J, Oda M. Second surgical intervention for recurrent and second primary bronchogenic carcinomas. Scand J Thorac Cardiovasc Surg 1992; 26:73-78
56. Curran WJ, Herbert SH, Stafford PM. Should patients with post-resection locoregional recurrence of lung cancer receive aggressive therapy? Int J Radiation Oncology Biol Phys 1992; 24:25-30
57. Green N, Kern W. The clinical course and treatment results of patients with postresection locally recurrent lung cancer. Cancer 1978; 42:2478-2482
58. Lamont JP, Kakuda JT, Smith D et al. Systematic postoperative radiologic follow-up in patients with non-small cell lung cancer for detecting second primary lung cancer in stage IA. Arch Surg 2002; 137:935-938
59. Chiu CH, Chern MS, Wu MH, et al. Usefulness of low-dose spiral CT of the chest in regular follow-up of postoperative non-small cell lung cancer patients: preliminary report. J Thorac Cardiovasc Surg 2003; 125:1300-1305
60. Ichinose Y. Counterpoint. In: Johnson FE, Virgo KS, eds. Cancer patient follow-up. St. Louis, MO: Mosby, 1997; 230-232
61. Antakli T, Schaefer RF, Rutherford JE, et al. Second primary lung cancer. Ann Thorac Surg 1995; 59:863-867
62. Adebonojo SA, Moritz DM, Danby CA. The results of modern surgical therapy for multiple primary lung cancers. Chest 1997; 112:693-701
63. Asaph JW, Keppel JF, Handy JR. Surgery for second lung cancers. Chest 2000; 118:1621-1625
64. Walsh GL, O'Connor M, Willis KM. Is follow-up of lung cancer patients after resection medically indicated and cost-effective? Ann Thorac Surg 1995; 60:1563-1572
65. Egermann U, Jaeggi K, Habicht JM, et al. Regular follow-up after curative resection of nonsmall cell lung cancer: a real benefit for patients? Eur Respir J 2002; 19:464-468
66. Kent MS, Korn P, Port JL, et al. Cost effectiveness of chest computed tomography after lung cancer resection: a decision analysis model. Ann Thorac Surg 2005; 80:1215-1223
67. Virgo KS, McKirgan LW, Caputo MCA, et al. Post-treatment management options for patients with lung cancer. Ann Surg 1995; 222:700-710
68. Younes RN, Gross JI, Deheinzelin D. Follow-up in lung cancer. Chest 1999; 115:1494-1499
69. Gilbert S, Reid KR, Lam MY, et al. Who should follow up lung cancer patients after operation? Ann Thorac Surg 2000; 69:1696-1700
70. Virgo KS, Naunheim KS, McKirgan LW. Cost of patient follow-up after potentially curative lung cancer treatment. J Thorac Cardiovasc Surg 1996; 112:356-363
71. Edelman MJ, Meyers FJ, Siegel D. The utility of follow-up testing after curative cancer therapy. J Gen Intern Med 1997; 12:318-331
72. Westeel V, Choma D, Clement F. Relevance of an intensive postoperative follow-up after surgery for non-small lung cancer. Ann Thorac Surg 2000; 70:1185-1190
73. Pujol J, Demoly P, Daures J. Chest tumor response measurement during lung cancer chemotherapy. Am Rev Respir Dis 1992; 148:1149-1154
74. Gorich J, Beyer-Enke SA, Flentje M. Evaluation of recurrent bronchogenic carcinoma by computed tomography. Clin Imag 1990; 14:131-137
75. Libshitz HI, Sheppard DG. Filling in of radiation therapy-induced bronchiectatic change. Radiology 1999; 210:25-27
76. Naunheim KS, Virgo KS, Coplin MA, et al. Clinical surveillance testing after lung cancer operations. Ann Thorac Surg 1995; 60:1612-1616
77. Johnson FE, Naunheim KS, Coplin MA, et al. How practice patterns in lung cancer patient follow-up are affected by surgeon age. Oncol Rep 1996; 3:851-855
78. Johnson FE, Naunheim KS, Coplin MA, et al. Geographic variation in the conduct of patient surveillance after lung cancer surgery. J Clin Oncol 1996; 14:2940-2949
79. Johnson FE, Naunheim KS, Coplin MA, et al. How tumor stage affects surgeons' surveillance strategies after lung cancer surgery. Chest 1997; 111:99-102
80. Virgo KS, Naunheim KS, Coplin MA, et al. Lung cancer patient follow-up. Chest 1998; 114:1519-1534
81. Shields TW. Postoperative lung cancer surveillance. Chest 1997; 111:11-12
82. Bruzzi JF, Munden RF, Bruzzi JF, et al. PET/CT imaging of lung cancer. J Thorac Imaging 2006; 21:123-136
83. Kubota K, Yamada S, Ishiwata K. Positron emission tomography for treatment evaluation and recurrence detection compared with CT in long-term follow-up of cases of lung cancer. Clin Nucl Med 1992; 17:877-881
84. Patz EF, Lowe VJ, Hoffman JM. Persistent or recurrent bronchogenic carcinoma: detection with PET and 2-[F-18]-2-deoxy-D-glucose. Radiology 1994; 191:379-382
85. Inoue T, Kim EE, Komaki R. Detecting recurrent or residual lung cancer with FDG-PET. J Nucl Med 1995; 36:788-793
86. Duhaylongsod FG, Lowe VJ, Patz EF. Detection of primary and recurrent lung cancer by means of F-18 fluorodeoxyglucose positron emission tomography (FDG PET) J Thorac Cardiovasc Surg 1995; 110:130-140
87. Hellwig D, Groschel A, Graeter TP, et al. Diagnostic performance and prognostic impact of FDG-PET in suspected recurrence of surgically treated non-small cell lung cancer. Eur J Nucl Med Mol Imaging 2006; 33:13-21
88. Bury T, Corhay JL, Duysinx B. Value of FDG-PET in detecting residual or recurrent NSCLC. Eur Respir J 1999; 14:1376-1380
89. Hassaballa HA, Cohen ES, Khan AJ, et al. Positron emission tomography demonstrates radiation-induced changes to nonirradiated lungs in lung cancer patients treated with radiation and chemotherapy. Chest 2005; 128:1448-1452
90. Shon IH, O'Doherty MJ, Maisey MN. Positron emission tomography in lung cancer. Semin Nucl Med 2002; 32:240-271
91. Buccheri G, Ferrigno D. Identifying patients at risk of early postoperative recurrence of lung cancer: a new use of the old CEA test. Ann Thorac Surg 2003; 75:973-980
92. Sawabati N, Ohta M, Takeda S. Serum carcinoembryonic antigen level in surgically resected clinical stage I patients with non-small cell lung cancer. Ann Thorac Surg 2002; 74:174-179
93. Stieber P, Zimmermann A, Reinmiedl J. CYFRA 21-1 in the early diagnosis of recurrent disease in nonsmall cell lung carcinomas. Anticancer Res 1999; 19:2665-2668
94. Khan N, Cromer CJ, Campa M, et al. Clinical utility of serum amyloid A and macrophage migration inhibitory factor as serum biomarkers for the detection of nonsmall cell lung carcinoma. Cancer 2004; 101:379-384
95. Niho S, Nishiwaki Y, Goto K. Significance of serum pro-gastrin-releasing peptide as a predictor of relapse of small cell lung cancer. Lung Cancer 2000; 27:159-167
96. Weigel TL, Kosco PJ, Dacic S. Postoperative fluorescence bronchoscopic surveillance in non-small cell lung cancer patients. Ann Thorac Surg 2001; 71:967-970
97. Weigel TL, Yousem S, Dacic S. Fluorescence bronchoscopic surveillance after curative surgical resection for non-small-cell lung cancer. Ann Surg Oncol 2000; 7:176-180
98. Gritz ER, Nisenbaum R, Elashoff RE, et al. Smoking behavior following diagnosis in patients with stage I non-small cell lung cancer. Cancer Causes Control 1991; 2:105-112
99. Richardson GE, Tucker MA, Venzon DJ. Smoking cessation after successful treatment of small cell lung cancer is associated with fewer smoking related second primary cancers. Ann Intern Med 1993; 119:383-390
100. Tucker MA, Murray N, Shaw EG. Second primary cancers related to smoking and treatment of small cell lung cancer. J Natl Cancer Inst 1997; 89:1782-1788
101. An LC, Zhu SH, Nelson DB, et al. Benefits of telephone care over primary care for smoking cessation: a randomized trial. Arch Intern Med 2006; 166:536-542
102. Kenford SL, Fiore MC. Promoting tobacco cessation and relapse prevention. Med Clin North Am 2004; 88:1553-1574
103. Wu S, Lin Z, Xu C. Multiple primary lung cancers. Chest 1987; 92:892-896
104. Van Bodegom PC, Wagenaar SS, Corrin B. Second primary lung cancer: importance of long term follow up. Thorax 1989; 44:788-793
105. Deschamps C, Pairolero PC, Trastek VF, et al. Multiple primary lung cancers. J Thorac Cardiovasc Surg 1990; 99:769-778
106. Westermann CJJ, van Swieten HA, Riviere AB. Pulmonary resection after pneumonectomy in patients with bronchogenic carcinoma. J Thorac Cardiovasc Surg 1993; 106:868-874
107. van Rens MTM, Zanen P, de la Rivier AB. Survival after resection of metachronous non-small cell lung cancer in 127 patients. Ann Thorac Surg 2001; 71:309-313
108. Battafarano RJ, Force SD, Meyers BF. Benefits of resection for metachronous lung cancer. J Thorac Cardiovasc Surg 2004; 127:836-842